Loading clinical trials...
Loading clinical trials...
A Randomized Phase II Study to Evaluate Oral RQC for the Prevention of Alzheimer's Disease and Retinal Amyloid-β
Conditions
Interventions
Resveratrol, Quercetin, and Curcumin (RQC)
Curcumin
Locations
1
United States
Zaparackas & Knepper Ltd.
Chicago, Illinois, United States
Start Date
July 1, 2024
Primary Completion Date
July 1, 2027
Completion Date
July 1, 2027
Last Updated
June 26, 2024
NCT07545473
NCT06223672
NCT04570085
NCT07531732
NCT07101380
NCT07290387
Lead Sponsor
Zaparackas and Knepper LTD
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions